UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012853
Receipt number R000015020
Scientific Title Phase 1 study of TM5509 -placebo controlled single dose study in male healthy adult subjects (high doses)-
Date of disclosure of the study information 2014/02/13
Last modified on 2014/11/03 10:16:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase 1 study of TM5509
-placebo controlled single dose study in male healthy adult subjects (high doses)-

Acronym

placebo controlled single dose study in male healthy adult subjects (high doses) (TM5509-1)

Scientific Title

Phase 1 study of TM5509
-placebo controlled single dose study in male healthy adult subjects (high doses)-

Scientific Title:Acronym

placebo controlled single dose study in male healthy adult subjects (high doses) (TM5509-1)

Region

Japan


Condition

Condition

Recover of hematogenesis after cord blood transplantation

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Investigation for safety of TM5509 in Japanese male healthy adult subjects.
Investigation for pharmacokinetics and pharmacodynamics of TM5509.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety of TM5509

Key secondary outcomes

Pharmacokinetics and pharmacodynamics of TM5509


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

TM5509

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Male

Key inclusion criteria

1. Male Japanese
2. From 20 years old to 45 years old at voluntary written consent
3. From 50.0 kg to 85.0 kg and from 18.5 to 25.0 of BMI at screening
4. Voluntary written consent by themselves is given before screening.

Key exclusion criteria

1. History of liver diseases, cardiovascular diseases, respiratory diseaases, gastroenteric diseases, kidney diseases, cerebralvascular diseases, cancer
2. Known hypersensitivity to some drugs and foods
3. Treatment by other doctors (included supplement) within 14 days before screening
4. Treatment with any investigational compound within 120 days before screening
5. History of TM5509 administration
6. History of blood taken
*>= 1200ml of all blood within 1 year before screening
*>= 400ml of all blood with 84 days before screening
*>= 200ml of all blood within 14 days before screening
7. Smoking status and treatment with anti-nicotine agents
8. Known active chronic hepatitis B or C, active syphilis and human immunodeficiency virus infection
9. Abuse of alcohol or drugs (included past history)
10. Bleeding, in the tendency to bleeding, and family history and past history of bleeding disorders
11. Somebody who are directed by principle investigator and employees in Hamamatsu University hospital
12. Any serious medical or psychiatric illness that could, in the opinion of the investigator, potentially interfere with the completion of treatment according to this protocol.

Target sample size

38


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuo Umemura

Organization

Hamamatsu University Hospital

Division name

Center for Clinical Research

Zip code


Address

Handayama 1-20-1, Higashi-ku, Hamamatsu

TEL

053-435-2006

Email

umemura@hama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name kazuo umemua

Organization

Hamamatsu University Hospital

Division name

Center for Clinical Research

Zip code


Address

Handayama 1-20-1, Higashi-ku, Hamamatsu

TEL

053-435-2006

Homepage URL

http://www2.hama-med.ac.jp/w6a/trial/index.html

Email

umemura@hama-med.ac.jp


Sponsor or person

Institute

Tohoku university school of medicine, molecular medicine and therapy, Toshio Miyata

Institute

Department

Personal name



Funding Source

Organization

ministry of education, culture, sports, science and technology

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医大附属病院(静岡県)


Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 02 Month 06 Day

Date of IRB


Anticipated trial start date

2014 Year 02 Month 13 Day

Last follow-up date

2014 Year 08 Month 31 Day

Date of closure to data entry

2014 Year 08 Month 31 Day

Date trial data considered complete

2014 Year 11 Month 30 Day

Date analysis concluded

2014 Year 11 Month 30 Day


Other

Other related information



Management information

Registered date

2014 Year 01 Month 15 Day

Last modified on

2014 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015020


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name